These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3264848)

  • 1. Lung function, smoking and survival in severe alpha 1-antitrypsin deficiency, PiZZ.
    Wu MC; Eriksson S
    J Clin Epidemiol; 1988; 41(12):1157-65. PubMed ID: 3264848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspects of treatment in alpha 1-antitrypsin deficiency: insights derived from a Swedish PiZZ series.
    Eriksson S; Wu MC
    Eur Respir J Suppl; 1990 Mar; 9():39s-43s. PubMed ID: 2340050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health status and lung function in the Swedish alpha 1-antitrypsin deficient cohort, identified by neonatal screening, at the age of 37-40 years.
    Piitulainen E; Mostafavi B; Tanash HA
    Int J Chron Obstruct Pulmon Dis; 2017; 12():495-500. PubMed ID: 28203073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decline in FEV
    Hiller AM; Piitulainen E; Jehpsson L; Tanash H
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1075-1083. PubMed ID: 31213789
    [No Abstract]   [Full Text] [Related]  

  • 5. Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ).
    Piitulainen E; Eriksson S
    Eur Respir J; 1999 Feb; 13(2):247-51. PubMed ID: 10065663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive smoking diminishes the differences in quality of life and exacerbation frequency between the alpha-1-antitrypsin deficiency genotypes PiZZ and PiSZ.
    Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R; Fähndrich S
    Respir Med; 2017 Sep; 130():1-8. PubMed ID: 29206626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group.
    Am J Respir Crit Care Med; 1998 Jul; 158(1):49-59. PubMed ID: 9655706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decline in FEV1 among patients with severe hereditary alpha 1-antitrypsin deficiency type PiZ.
    Seersholm N; Kok-Jensen A; Dirksen A
    Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1922-5. PubMed ID: 8520756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term evolution of lung function in individuals with alpha-1 antitrypsin deficiency from the Spanish registry (REDAAT).
    Esquinas C; Serreri S; Barrecheguren M; Rodriguez E; Nuñez A; Casas-Maldonado F; Blanco I; Pirina P; Lara B; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1001-1007. PubMed ID: 29615836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exacerbations and duration of smoking abstinence are associated with the annual loss of FEV
    Fähndrich S; Bernhard N; Lepper PM; Vogelmeier C; Seibert M; Wagenpfeil S; Bals R
    Respir Med; 2017 Aug; 129():8-15. PubMed ID: 28732839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung function in 30-year-old alpha-1-antitrypsin-deficient individuals.
    Bernspång E; Wollmer P; Sveger T; Piitulainen E
    Respir Med; 2009 Jun; 103(6):861-5. PubMed ID: 19181511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking, lung function, and alpha 1-antitrypsin deficiency.
    Janus ED; Phillips NT; Carrell RW
    Lancet; 1985 Jan; 1(8421):152-4. PubMed ID: 2857224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival in relation to lung function and smoking cessation in patients with severe hereditary alpha 1-antitrypsin deficiency.
    Seersholm N; Kok-Jensen A
    Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):369-73. PubMed ID: 7842193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung function and CT lung densitometry in 37- to 39-year-old individuals with alpha-1-antitrypsin deficiency.
    Mostafavi B; Diaz S; Piitulainen E; Stoel BC; Wollmer P; Tanash HA
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3689-3698. PubMed ID: 30510411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-1-antitrypsin deficiency: smoking, decline in lung function and implications for therapeutic trials.
    Hutchison DC; Cooper D;
    Respir Med; 2002 Nov; 96(11):872-80. PubMed ID: 12418584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of age and occupational exposure to airway irritants on lung function in non-smoking individuals with alpha 1-antitrypsin deficiency (PiZZ).
    Piitulainen E; Tornling G; Eriksson S
    Thorax; 1997 Mar; 52(3):244-8. PubMed ID: 9093340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decline in pulmonary function in patients with alpha 1-antitrypsin deficiency.
    Evald T; Dirksen A; Keittelmann S; Viskum K; Kok-Jensen A
    Lung; 1990; 168 Suppl():579-85. PubMed ID: 2117166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of smoking and intermediate alpha 1-antitrypsin deficiency (PiMZ) on lung function.
    Eriksson S; Lindell SE; Wiberg R
    Eur J Respir Dis; 1985 Oct; 67(4):279-85. PubMed ID: 3878302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits.
    Tanash HA; Ekström M; Rönmark E; Lindberg A; Piitulainen E
    Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28889108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individualized lung function trends in alpha-1-antitrypsin deficiency: a need for patience in order to provide patient centered management?
    Stockley RA; Edgar RG; Pillai A; Turner AM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1745-56. PubMed ID: 27536086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.